Dexcom Inc
Change company Symbol lookup
Select an option...
DXCM Dexcom Inc
CEVIY China Everbright Ltd
PATK Patrick Industries Inc
TGHI Touchpoint Group Holdings Inc
PIAI^ Prime Impact Acquisition I
CGEN Compugen Ltd
FPAY FlexShopper Inc
IOACW Innovative International Acquisition Equity Warrants Exp 26th Oct 2026 *W EXP 10/26/2026
FUSN Fusion Pharmaceuticals Inc
COUR Coursera Inc
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profile

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for use by people with diabetes and by healthcare providers. Its Dexcom G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an application on the patient's mobile device to wirelessly transmit glucose information to the cloud and then to applications on the mobile devices of up to five designated recipients. Its Dexcom Real-Time API enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices. Its other products include Dexcom ONE and Dexcom G7.

Closing Price
$89.83
Day's Change
1.59 (1.80%)
Bid
--
Ask
--
B/A Size
--
Day's High
89.90
Day's Low
87.60
Volume
(Light)
Volume:
1,914,913

10-day average volume:
3,752,214
1,914,913

Display:

Providers:

UpdateCancel
6 providers
August 03, 2022
Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022 at...(BusinessWire)

August 01, 2022
Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, and NHS England today announced the availability of the easy to use Dexcom ONE rt-CGM System on prescription via the NHS England...(BusinessWire)

July 28, 2022
Dexcom Reports Second Quarter 2022 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2022. Second Quarter 2022 Financial Highlights: Revenue grew 17% versus the same quarter of the prior year to $696.2 million on a reported...(BusinessWire)

July 27, 2022
Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish

Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of the Dexcom G6 mobile app in Spanish, available immediately for users with a compatible iOS...(BusinessWire)

July 19, 2022
Dexcom Canada Achieves Great Place to Work(R) Certification

Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (rtCGM), is proud to announce that it is certified as a Great Place to Work(R) in Canada for 2022-23. Awarded by Great Place to Work Institute(R) Canada, the...(BusinessWire)

June 30, 2022
Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2022 financial results after market close on Thursday, July 28, 2022. Management will hold a conference call to review the company's second quarter 2022...(BusinessWire)

June 13, 2022
Come Chill at Dexcom's 'No Pricks Parlour' With Ed Gamble for Diabetes Awareness Week, Celebrating You!

Come chill with us! This week is Diabetes Awareness Week and DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (rt-CGM) for people with diabetes, is honouring the theme of 'celebrating you' with its 'No Pricks...(BusinessWire)

June 02, 2022
Dexcom to Showcase Expanded CGM Portfolio and Industry-leading Connectivity at 82nd Scientific Sessions of the American Diabetes Association

DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, will showcase its expanded global portfolio of real-time continuous glucose monitoring (CGM) systems at the 82nd Scientific Sessions...(BusinessWire)

June 01, 2022
Prince Edward Island Becomes a National Leader in Providing Coverage for Dexcom G6 Continuous Glucose Monitoring System for Canadians With Diabetes

Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), announced today that people with type 1 and type 2 diabetes age two and over on multiple daily injections of insulin (three or more) or who use an...(BusinessWire)

May 31, 2022
Dexcom Issues Statement on Recent Market Speculation

DexCom, Inc. (NASDAQ:DXCM) today issued the following statement in response to recent media and market speculation: "Like many companies, Dexcom's Board and management team regularly review opportunities to enhance stockholder value and create...(BusinessWire)

May 23, 2022
Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and Diabetes Symposium on Wednesday, May 25, 2022 at 1:00 p.m. (EDT). (BusinessWire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.